Shaji Ramachandran Velayudhan

Department of Clinical Haematology, Christian Medical College

Affiliated withChristian Medical College Thiruvalluvar University

Research Area

Biography

Shaji Ramachandran Velayudhan has not added Biography.
If you are Shaji Ramachandran Velayudhan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2022

Other Publications

Article	Year
A novel beta-thalassemia mutation in an Asian Indian. Hemoglobin\| PubMed ID: 11939512	2002
Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. American journal of hematology\| PubMed ID: 12210810	2002
Coexistence of a novel beta-globin gene deletion (codons 81-87) with the codon 30 (G-->C) mutation in an Indian patient with beta0-thalassemia. Hemoglobin\| PubMed ID: 12403488	2002
Hb Lepore in the Indian population. Hemoglobin\| PubMed ID: 12603088	2003
Rapid detection of beta-globin gene mutations and polymorphisms by temporal temperature gradient gel electrophoresis. Clinical chemistry\| PubMed ID: 12709369	2003
Determination of the breakpoint and molecular diagnosis of a common alpha-thalassaemia-1 deletion in the Indian population. British journal of haematology\| PubMed ID: 14632787	2003
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood\| PubMed ID: 16352810	2006
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20644086	2010
Chorionic villous sampling through transvaginal ultrasound approach: A retrospective analysis of 1138 cases. The journal of obstetrics and gynaecology research\| PubMed ID: 27352773	2016
Identification of Stable OCT4NANOG State in Somatic Cell Reprogramming. Cellular reprogramming\| PubMed ID: 27622636	2016
Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biology open\| PubMed ID: 28089995	2017
Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem cell research\| PubMed ID: 28395741	2017
Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2. PloS one\| PubMed ID: 28505160	2017
Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual. Stem cell research\| PubMed ID: 29665501	2018
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients. Scientific reports\| PubMed ID: 33244077	2020
kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Leukemia & lymphoma\| PubMed ID: 33478278	2021
Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 33830454	2021
Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 33950379	2021